Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China · Delayed Price · Currency is CNY 25.92
-0.50 (-1.89%)
At close: Apr 15, 2026
SHE:001367 Revenue
In the year 2025, Zhejiang Haisen Pharmaceutical had annual revenue of 532.26M CNY with 12.88% growth. Zhejiang Haisen Pharmaceutical had revenue of 173.39M in the quarter ending December 31, 2025, with 14.48% growth.
Revenue
532.26M
Revenue Growth
+12.88%
P/S Ratio
7.32
Revenue / Employee
754.98K
Employees
663
Market Cap
3.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 532.26M | 60.75M | 12.88% |
| Dec 31, 2024 | 471.51M | 74.06M | 18.63% |
| Dec 31, 2023 | 397.45M | -25.32M | -5.99% |
| Jan 1, 2023 | 422.78M | 33.79M | 8.69% |
| Dec 31, 2021 | 388.98M | 104.18M | 36.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.96B |
| Zhejiang Int'l Group | 33.54B |
| Zhejiang Zhenyuan Share | 2.67B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.88B |
| Chongqing Lummy Pharmaceutical | 775.69M |
| Hangzhou Minsheng Healthcare | 744.06M |
| Hubei Guangji Pharmaceutical | 605.87M |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |